Your browser is no longer supported. Please, upgrade your browser.
Settings
AMPE [AMEX]
Ampio Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.08 Insider Own0.10% Shs Outstand196.18M Perf Week5.13%
Market Cap310.50M Forward P/E- EPS next Y-0.07 Insider Trans-46.53% Shs Float186.32M Perf Month17.14%
Income-15.20M PEG- EPS next Q-0.02 Inst Own27.40% Short Float12.66% Perf Quarter-10.87%
Sales- P/S- EPS this Y11.90% Inst Trans38.58% Short Ratio12.42 Perf Half Y-9.39%
Book/sh0.10 P/B16.40 EPS next Y12.50% ROA-70.00% Target Price- Perf Year74.21%
Cash/sh0.11 P/C15.15 EPS next 5Y- ROE-93.10% 52W Range0.72 - 2.98 Perf YTD3.14%
Dividend- P/FCF- EPS past 5Y26.60% ROI- 52W High-42.62% Beta1.75
Dividend %- Quick Ratio7.10 Sales past 5Y- Gross Margin- 52W Low137.24% ATR0.13
Employees18 Current Ratio7.10 Sales Q/Q- Oper. Margin- RSI (14)55.89 Volatility12.15% 8.18%
OptionableYes Debt/Eq0.00 EPS Q/Q-10.50% Profit Margin- Rel Volume0.84 Prev Close1.64
ShortableYes LT Debt/Eq0.00 EarningsAug 04 AMC Payout- Avg Volume1.90M Price1.71
Recom2.00 SMA207.41% SMA5013.67% SMA2001.89% Volume976,797 Change4.27%
Dec-19-19Initiated ROTH Capital Buy $4
Mar-17-14Reiterated Aegis Capital Buy $15 → $16
Sep-25-12Initiated Aegis Capital Buy $11
Sep-21-21 09:15AM  
Sep-15-21 02:54PM  
09:15AM  
Aug-13-21 09:15AM  
Aug-12-21 09:15AM  
Aug-11-21 09:15AM  
Aug-05-21 01:24PM  
Aug-04-21 04:01PM  
Jul-29-21 09:15AM  
Jul-28-21 09:15AM  
Jul-27-21 09:15AM  
Jul-14-21 09:15AM  
Jun-25-21 09:15AM  
Jun-18-21 09:15AM  
Jun-17-21 09:15AM  
Jun-15-21 07:11AM  
06:15AM  
Jun-14-21 06:15AM  
Jun-11-21 09:15AM  
May-21-21 09:15AM  
May-10-21 09:15AM  
May-05-21 04:01PM  
02:45PM  
Apr-27-21 10:39AM  
09:15AM  
09:15AM  
Apr-21-21 09:15AM  
Apr-19-21 09:15AM  
Apr-06-21 09:15AM  
Apr-01-21 09:57AM  
Mar-29-21 09:15AM  
Mar-19-21 09:15AM  
Mar-16-21 09:15AM  
Mar-10-21 04:01PM  
Mar-04-21 12:33PM  
01:30AM  
Mar-03-21 04:01PM  
02:30PM  
09:15AM  
Feb-24-21 09:15AM  
Feb-23-21 09:15AM  
Feb-16-21 09:15AM  
Feb-01-21 09:15AM  
Jan-14-21 09:15AM  
Jan-04-21 09:15AM  
Dec-29-20 03:59PM  
09:15AM  
Dec-23-20 03:33PM  
Dec-17-20 09:15AM  
Dec-15-20 08:56AM  
Dec-10-20 09:15AM  
Dec-08-20 09:15AM  
Dec-02-20 09:15AM  
Dec-01-20 08:44AM  
Nov-25-20 09:15AM  
Nov-17-20 09:15AM  
Nov-16-20 11:15PM  
Nov-10-20 04:01PM  
Nov-05-20 03:45PM  
Nov-02-20 09:15AM  
Oct-28-20 07:30AM  
Oct-27-20 09:15AM  
Oct-26-20 09:15AM  
Oct-08-20 09:15AM  
Sep-21-20 09:15AM  
Sep-14-20 09:15AM  
Sep-09-20 09:15AM  
Sep-04-20 09:15AM  
Aug-19-20 08:00AM  
Jul-31-20 02:43PM  
Jul-23-20 08:00AM  
Jul-20-20 08:00AM  
Jun-29-20 11:31AM  
Jun-19-20 08:00AM  
May-22-20 08:00AM  
May-21-20 06:45AM  
May-11-20 08:00AM  
Apr-16-20 08:37AM  
Apr-02-20 10:41AM  
09:00AM  
Mar-24-20 07:00AM  
06:30AM  
Feb-21-20 06:30AM  
Dec-23-19 07:57PM  
Dec-04-19 08:30AM  
Oct-10-19 08:30AM  
Sep-18-19 08:30AM  
Sep-17-19 08:30AM  
Aug-22-19 08:30AM  
Jul-25-19 08:30AM  
Jul-11-19 08:30AM  
Jul-10-19 08:30AM  
Jun-19-19 04:01PM  
Jun-17-19 08:16AM  
Jun-14-19 04:01PM  
07:30AM  
May-22-19 08:30AM  
Apr-29-19 08:00AM  
Mar-26-19 07:34PM  
Mar-06-19 08:30AM  
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunology-based therapies for the treatment of prevalent inflammatory conditions in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-016, an intravenous treatment that is in Phase I/II clinical trial for COVID-19 patients with respiratory illness; and AP-014, an inhaled treatment that is in Phase I clinical trial for COVID-19 induced respiratory distress. The company is headquartered in Englewood, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
STOKELY DANCFOJun 25Option Exercise0.4322,5009,67550,815Jun 29 11:22 AM
STOKELY DANCFOJun 25Sale1.7922,50040,27528,315Jun 29 11:22 AM
COELHO PHILIP HDirectorMay 21Option Exercise0.406,7372,695210,237May 25 03:44 PM
Cherevka HolliCHIEF OPERATING OFFICERMay 21Option Exercise0.512,6031,3282,603May 25 03:45 PM
COELHO PHILIP HDirectorMay 21Sale2.006,73713,474203,500May 25 03:44 PM
Cherevka HolliCHIEF OPERATING OFFICERMay 21Sale2.002,6035,2060May 25 03:45 PM
STOKELY DANCFOMay 18Sale1.8335,00063,98028,315May 19 05:56 PM
STOKELY DANCFOMay 17Option Exercise0.4335,00015,05063,315May 19 05:56 PM
COELHO PHILIP HDirectorApr 29Option Exercise0.403,2631,305206,763Apr 29 09:37 PM
COELHO PHILIP HDirectorApr 29Sale2.003,2636,526203,500Apr 29 09:37 PM
Cherevka HolliCHIEF OPERATING OFFICERApr 27Option Exercise0.5174,63138,06274,631Apr 29 09:36 PM
COELHO PHILIP HDirectorApr 27Option Exercise0.4020,0008,000223,500Apr 29 09:38 PM
Cherevka HolliCHIEF OPERATING OFFICERApr 27Sale2.0074,631149,2620Apr 29 09:36 PM
COELHO PHILIP HDirectorApr 27Sale2.0020,00040,000203,500Apr 29 09:38 PM
STOKELY DANCFOMar 16Option Exercise0.4340,00017,20068,315Mar 17 06:35 PM
STOKELY DANCFOMar 16Sale1.8340,00073,04828,315Mar 17 06:35 PM
STOKELY DANCFOFeb 12Option Exercise2.5552,500133,87552,500Feb 17 02:51 PM